Filter News
Area of Research
- Biological Systems (1)
- Biology and Environment (39)
- Clean Energy (19)
- Computational Biology (2)
- Computational Engineering (2)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion and Fission (4)
- Isotopes (6)
- Materials (14)
- Materials for Computing (3)
- Mathematics (1)
- National Security (3)
- Neutron Science (12)
- Nuclear Science and Technology (6)
- Supercomputing (30)
News Topics
- (-) Biomedical (61)
- (-) Clean Water (31)
- (-) Molten Salt (9)
- (-) Simulation (51)
- 3-D Printing/Advanced Manufacturing (128)
- Advanced Reactors (34)
- Artificial Intelligence (101)
- Big Data (60)
- Bioenergy (92)
- Biology (101)
- Biotechnology (24)
- Buildings (67)
- Chemical Sciences (73)
- Climate Change (105)
- Composites (30)
- Computer Science (198)
- Coronavirus (46)
- Critical Materials (29)
- Cybersecurity (35)
- Decarbonization (85)
- Education (5)
- Element Discovery (1)
- Emergency (2)
- Energy Storage (112)
- Environment (200)
- Exascale Computing (42)
- Fossil Energy (6)
- Frontier (45)
- Fusion (58)
- Grid (66)
- High-Performance Computing (93)
- Hydropower (11)
- Irradiation (3)
- Isotopes (57)
- ITER (7)
- Machine Learning (50)
- Materials (147)
- Materials Science (146)
- Mathematics (9)
- Mercury (12)
- Microelectronics (4)
- Microscopy (51)
- Nanotechnology (60)
- National Security (72)
- Net Zero (14)
- Neutron Science (137)
- Nuclear Energy (111)
- Partnerships (51)
- Physics (64)
- Polymers (33)
- Quantum Computing (37)
- Quantum Science (72)
- Renewable Energy (2)
- Security (25)
- Software (1)
- Space Exploration (25)
- Statistics (3)
- Summit (59)
- Sustainable Energy (130)
- Transformational Challenge Reactor (7)
- Transportation (99)
Media Contacts
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
As the rise of antibiotic-resistant bacteria known as superbugs threatens public health, Oak Ridge National Laboratory’s Shuo Qian and Veerendra Sharma from the Bhaba Atomic Research Centre in India are using neutron scattering to study how an antibacterial peptide interacts with and fights harmful bacteria.
OAK RIDGE, Tenn., March 4, 2019—A team of researchers from the Department of Energy’s Oak Ridge National Laboratory Health Data Sciences Institute have harnessed the power of artificial intelligence to better match cancer patients with clinical trials.
Oak Ridge National Laboratory scientists analyzed more than 50 years of data showing puzzlingly inconsistent trends about corrosion of structural alloys in molten salts and found one factor mattered most—salt purity.
While studying the genes in poplar trees that control callus formation, scientists at Oak Ridge National Laboratory have uncovered genetic networks at the root of tumor formation in several human cancers.
A team of scientists, led by University of Guelph professor John Dutcher, are using neutrons at ORNL’s Spallation Neutron Source to unlock the secrets of natural nanoparticles that could be used to improve medicines.
Scientists from Oak Ridge National Laboratory performed a corrosion test in a neutron radiation field to support the continued development of molten salt reactors.
Experts focused on the future of nuclear technology will gather at Oak Ridge National Laboratory for the fourth annual Molten Salt Reactor Workshop on October 3–4.
A team led by Oak Ridge National Laboratory has discovered that residents living in arid environments share a desire for water security, which can ultimately benefit entire neighborhoods. Las Vegas, Nevada’s water utility was the first utility in the United States to implement ...
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.